ZA96722B - Combination therapy for hiv infection - Google Patents

Combination therapy for hiv infection

Info

Publication number
ZA96722B
ZA96722B ZA96722A ZA96722A ZA96722B ZA 96722 B ZA96722 B ZA 96722B ZA 96722 A ZA96722 A ZA 96722A ZA 96722 A ZA96722 A ZA 96722A ZA 96722 B ZA96722 B ZA 96722B
Authority
ZA
South Africa
Prior art keywords
combination therapy
hiv infection
hiv
infection
therapy
Prior art date
Application number
ZA96722A
Other languages
English (en)
Inventor
Jeffrey A Chodakewitz
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA96722B publication Critical patent/ZA96722B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA96722A 1995-02-01 1996-01-31 Combination therapy for hiv infection ZA96722B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection

Publications (1)

Publication Number Publication Date
ZA96722B true ZA96722B (en) 1996-08-26

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96722A ZA96722B (en) 1995-02-01 1996-01-31 Combination therapy for hiv infection

Country Status (38)

Country Link
US (1) US6689761B1 (fr)
EP (1) EP0806957B1 (fr)
JP (1) JPH10513186A (fr)
KR (1) KR19980701856A (fr)
CN (1) CN1160081C (fr)
AR (1) AR002957A1 (fr)
AT (1) ATE243519T1 (fr)
AU (1) AU711176B2 (fr)
BR (1) BR9607714A (fr)
CA (1) CA2211973A1 (fr)
CO (1) CO4700430A1 (fr)
CZ (1) CZ244497A3 (fr)
DE (1) DE69628819T2 (fr)
DK (1) DK0806957T3 (fr)
DZ (1) DZ1988A1 (fr)
EA (1) EA000437B1 (fr)
EE (1) EE03514B1 (fr)
ES (1) ES2200052T3 (fr)
FI (1) FI973184A (fr)
HK (1) HK1004659A1 (fr)
HR (1) HRP960045B1 (fr)
HU (1) HUP9800810A3 (fr)
IL (1) IL116925A (fr)
IS (1) IS1970B (fr)
MX (1) MX9705916A (fr)
MY (1) MY121604A (fr)
NO (1) NO314568B1 (fr)
NZ (1) NZ302153A (fr)
PE (1) PE38397A1 (fr)
PL (1) PL182742B1 (fr)
PT (1) PT806957E (fr)
SA (1) SA96160669B1 (fr)
SK (1) SK103797A3 (fr)
TR (1) TR199700735T1 (fr)
TW (1) TW442291B (fr)
WO (1) WO1996023509A1 (fr)
YU (1) YU49417B (fr)
ZA (1) ZA96722B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008539A1 (fr) * 1996-08-26 1998-03-05 Chiron Corporation Therapie de vaccination apres l'infection par le virus de l'immunodeficience humaine (vih)
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
CA2374198A1 (fr) * 1998-05-29 1999-12-02 Maki Arai Therapie combinee pour le traitement des infections dues au vif
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性hivc型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
CA2452015C (fr) 2001-07-05 2012-07-03 Chiron Corporation Polynucleotides codant des polypeptides de type c du vih antigeniques, polypeptides et leurs utilisations
WO2006055754A1 (fr) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Procede visant a traiter l'infection a vih par l'administration combinee du tipranavir et du reverset
CA2616592C (fr) * 2005-07-27 2014-09-09 Emil Toma Compositions de lamivudine (3tc) potentialisees par la zalcitabine (ddc) pour traitement antiretroviral
WO2018128993A1 (fr) * 2017-01-04 2018-07-12 Oyagen, Inc. Composés, compositions et méthodes pour le traitement du virus de l'immunodéficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
SI9420017B (sl) 1993-03-31 2003-12-31 Merck & Co. Inc. Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
HUP9800810A3 (en) 2001-05-28
IL116925A0 (en) 1996-05-14
IS4533A (is) 1997-07-29
WO1996023509A1 (fr) 1996-08-08
CN1179722A (zh) 1998-04-22
EE03514B1 (et) 2001-10-15
MY121604A (en) 2006-02-28
BR9607714A (pt) 1998-01-13
AU4774896A (en) 1996-08-21
TR199700735T1 (xx) 1998-02-21
CA2211973A1 (fr) 1996-08-08
FI973184A0 (fi) 1997-07-31
US6689761B1 (en) 2004-02-10
CZ244497A3 (cs) 1998-01-14
PT806957E (pt) 2003-10-31
NO973533L (no) 1997-10-01
HK1004659A1 (en) 1998-12-04
YU6396A (sh) 1999-06-15
YU49417B (sh) 2006-01-16
MX9705916A (es) 1997-10-31
EE9700165A (et) 1998-02-16
DE69628819D1 (de) 2003-07-31
EP0806957B1 (fr) 2003-06-25
PE38397A1 (es) 1997-10-09
ES2200052T3 (es) 2004-03-01
DK0806957T3 (da) 2003-09-29
CO4700430A1 (es) 1998-12-29
JPH10513186A (ja) 1998-12-15
DE69628819T2 (de) 2004-05-13
HRP960045A2 (en) 1997-10-31
EA199700150A1 (ru) 1997-12-30
IS1970B (is) 2004-12-15
FI973184A (fi) 1997-09-30
NO973533D0 (no) 1997-07-31
SA96160669B1 (ar) 2006-07-30
ATE243519T1 (de) 2003-07-15
HUP9800810A2 (hu) 1998-07-28
SK103797A3 (en) 1998-02-04
PL321660A1 (en) 1997-12-22
CN1160081C (zh) 2004-08-04
NZ302153A (en) 1998-12-23
NO314568B1 (no) 2003-04-14
EA000437B1 (ru) 1999-08-26
PL182742B1 (pl) 2002-02-28
KR19980701856A (ko) 1998-06-25
TW442291B (en) 2001-06-23
AU711176B2 (en) 1999-10-07
EP0806957A1 (fr) 1997-11-19
IL116925A (en) 2000-07-26
DZ1988A1 (fr) 2002-07-20
HRP960045B1 (en) 2004-06-30
AR002957A1 (es) 1998-05-27

Similar Documents

Publication Publication Date Title
EP0707855A3 (fr) Thérapie combinée contre une infection de l'hépatite C chronique
AU7557494A (en) Infection resistant medical devices
HUP9901089A3 (en) Medical splint
GB9517022D0 (en) Medicaments
AU7973994A (en) Combination therapy for hiv infection
GB9519033D0 (en) Treatment
HRP960045B1 (en) Combination therapy for hiv infection
ZA955269B (en) Combination therapy for HIV infection
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
GB9524942D0 (en) Drug therapy
GB9503850D0 (en) Medicaments
EP0830862A4 (fr) Medicaments anti-vih
AU5419894A (en) Dental treatment aid
ZA956662B (en) Combination therapy for HIV infection
GB9526264D0 (en) Medical treatment
EP0724882A4 (fr) Nouveau medicament anti vih
GB9524722D0 (en) Syringes
GB9514118D0 (en) Novel attenvated HIV vaccine
GB2307858B (en) Medical treatment
GB9505272D0 (en) Combination therapy
GB9506161D0 (en) Medical aid
GB9701117D0 (en) HIV Treatment
GB9708380D0 (en) HIV treatment
GB9512940D0 (en) Patient handling means